Literature DB >> 15823922

Novel mutations in MYO7A and USH2A in Usher syndrome.

Cécilia Maubaret1, Jean-Michel Griffoin, Bernard Arnaud, Christian Hamel.   

Abstract

PURPOSE: Usher syndrome is an autosomal recessive disease associating retinitis pigmentosa and neurosensory deafness. Three clinical types (USH1, USH2, USH3) and 11 mutated genes or loci have been described. Mutations in MYO7A and USH2A are responsible for about 40% and 60% of Usher syndromes type 1 and 2, respectively. These genes were screened in a series of patients suffering from Usher syndrome.
METHODS: We performed SSCP screening of MYO7A in 12 unrelated patients suffering from Usher syndrome type 1 (USH1) and USH2A in 28 unrelated patients affected by Usher syndrome type 2 (USH2). RESULTS/
CONCLUSIONS: Six mutations in MYO7A were found in five patients, including two novel mutations c.397C > G (His133Asp) and 1244-2A > G (Glu459Stop), accounting for 42% of our USH1 patients. Twelve mutations in USH2A were found in 11 patients, including four new mutations c.850delGA, c.1841-2A > G, c.3129insT, and c.3920C > G (Ser1307Stop), accounting for 39% of our USH2 patients

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823922     DOI: 10.1080/13816810590918118

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  6 in total

1.  Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations.

Authors:  Gema Garcia-Garcia; Maria J Aparisi; Teresa Jaijo; Regina Rodrigo; Ana M Leon; Almudena Avila-Fernandez; Fiona Blanco-Kelly; Sara Bernal; Rafael Navarro; Manuel Diaz-Llopis; Montserrat Baiget; Carmen Ayuso; Jose M Millan; Elena Aller
Journal:  Orphanet J Rare Dis       Date:  2011-10-17       Impact factor: 4.123

2.  Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%.

Authors:  A-F Roux; V Faugère; S Le Guédard; N Pallares-Ruiz; A Vielle; S Chambert; S Marlin; C Hamel; B Gilbert; S Malcolm; M Claustres
Journal:  J Med Genet       Date:  2006-05-05       Impact factor: 6.318

3.  Molecular biology of hearing.

Authors:  Timo Stöver; Marc Diensthuber
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

4.  Complete exon sequencing of all known Usher syndrome genes greatly improves molecular diagnosis.

Authors:  Crystel Bonnet; M'hamed Grati; Sandrine Marlin; Jacqueline Levilliers; Jean-Pierre Hardelin; Marine Parodi; Magali Niasme-Grare; Diana Zelenika; Marc Délépine; Delphine Feldmann; Laurence Jonard; Aziz El-Amraoui; Dominique Weil; Bruno Delobel; Christophe Vincent; Hélène Dollfus; Marie-Madeleine Eliot; Albert David; Catherine Calais; Jacqueline Vigneron; Bettina Montaut-Verient; Dominique Bonneau; Jacques Dubin; Christel Thauvin; Alain Duvillard; Christine Francannet; Thierry Mom; Didier Lacombe; Françoise Duriez; Valérie Drouin-Garraud; Marie-Françoise Thuillier-Obstoy; Sabine Sigaudy; Anne-Marie Frances; Patrick Collignon; Georges Challe; Rémy Couderc; Mark Lathrop; José-Alain Sahel; Jean Weissenbach; Christine Petit; Françoise Denoyelle
Journal:  Orphanet J Rare Dis       Date:  2011-05-11       Impact factor: 4.123

5.  Predicting pathogenicity for novel hearing loss mutations based on genetic and protein structure approaches.

Authors:  Paula I Buonfiglio; Carlos D Bruque; Vanesa Lotersztein; Leonela Luce; Florencia Giliberto; Sebastián Menazzi; Liliana Francipane; Bibiana Paoli; Ernesto Goldschmidt; Ana Belén Elgoyhen; Viviana Dalamón
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

6.  [Usher syndrome: about a case].

Authors:  Chama Daoudi; Noureddine Boutimzine; Samia El Haouzi; Omar Lezrek; Samira Tachfouti; Mounir Lezrek; Mina Laghmari; Rajae Daoudi
Journal:  Pan Afr Med J       Date:  2017-07-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.